In-Silico and Biological Analysis of B-Cell Lymphoma-2 Gene and Genetic Mutation as Diagnostic Marker in Childhood Sudanese Acute Lymphoblastic Leukemia Patients, Gezira State, Sudan (2018)
Objective: To analyze the BCL2 genetic as diagnostic marker among acute lymphoblastic leukemia in childhood Sudanese patients, to detect genetic polymorphism in BCL2 in childhood acute lymphoblastic leukemia patients using Polymerase chain reaction (PCR) and DNA sequencing technique to confirm the harmfulness of the detected mutation using in silico analysis. Material and Methods: Venous blood was drained by means of clean venipuncture into a labeled 5 ml K-EDTA tubes. Subsequent mixing of blood with anticoagulant was followed and the tubes were stored at -20°C, 40 blood samples were carried out using Sysmex XP-300 automated hematology analyzer, DNA extraction using innuPREP blood DNA mini extraction kit, quality of the purified DNA was evaluated by electrophoresis in 0.25 g agarose gel & DNA amplification using polymerase chain reaction Results: In this study, sequencing showed that harmful mutation of a homozygous AA allele in one case of pre B-ALL and a heterozygous mutation AC allele in one control, BCL2 promoter region polymorphism is more reliable gene promoter polymorphism in ALL.
Cite this paper
Abdalaziz, S. , Abbas, A. A. , Allah, S. F. , Abdelhammed, Y. , Ahmed, O. Y. M. and Altayb, H. N. (2022). In-Silico and Biological Analysis of B-Cell Lymphoma-2 Gene and Genetic Mutation as Diagnostic Marker in Childhood Sudanese Acute Lymphoblastic Leukemia Patients, Gezira State, Sudan (2018). Open Access Library Journal, 9, e9400. doi: http://dx.doi.org/10.4236/oalib.1109400.
Gustafsson, G.R., Hjalgrim, H., Kristinsson, J., Vettenranta, K., Schmiegelow, K., Rostgaard, K., et al. (2003) Age- and Sex-Specific Incidence of Childhood Leukemia by Immunophenotype in the Nordic Countries. JNCI: Journal of the National Cancer Institute, 95, 1539-1544. https://doi.org/10.1093/jnci/djg064
Ma, H., Sun, H. and Sun, X. (2014) Survival Improvement by Decade of Patients Aged 0-14 Years with Acute Lymphoblastic Leukemia: A SEER Analysis. Scientific Reports, 4, Article No. 4227. https://doi.org/10.1038/srep04227
Hogarth, L.A. and Hall, A.G. (1999) Increased BAX Expression Is Associated with an Increased Risk of Relapse in Childhood Acute Lymphocytic Leukemia. Blood, 93, 2671-2678. https://doi.org/10.1182/blood.V93.8.2671
Menendez, P., Vargas, A., Bueno, C., Barrena, S., Almeida, J., De Santiago, M., et al. (2004) Quantitative Analysis of bcl-2 Expression in Normal and Leukemic Human B-Cell Differentiation. Leukemia, 18, 491-498.
https://doi.org/10.1038/sj.leu.2403231
Arico, A.B., Pui, C., et al. (2011) Prolonged Survival of B-Lineage Acute Lymphoblastic Leukemia Cells Is Accompanied by Overexpression of bcl-2 Protein. Blood, 81, 1025-1031.
Pinto, G.R., Overal, D.J., de Moraes, L.S., Van Den Berg, A.V., Lemos, J.A.R., Smith, M.d.A.C., et al. (2005) Cytogenetic Characteristics of Patients with Signs and Symptoms of Myelodysplastic Syndromes in the State of Pará, Brazil. Genetics and Molecular Research, 4, 18-30.
Harrison, C.J. (2001) The Detection and Significance of Chromosomal Abnormalities in Childhood Acute Lymphoblastic Leukaemia. Blood Reviews, 15, 49-59.
https://doi.org/10.1054/blre.2001.0150
Pui, C.-H., Campana, D. and Evans, W.E. (2001) Childhood Acute Lymphoblastic Leukaemia-Current Status and Future Perspectives. The Lancet Oncology, 2, 597-607. https://doi.org/10.1016/S1470-2045(01)00516-2
Wojcik, I., Szybka, M., Golanska, E., Rieske, P., Blonski, J., Robak, T., et al. (2005) Abnormalities of the P53, MDM2, BCL2 and BAX Genes in Acute Leukemias. Neoplasma, 52, 318-324.
Schultz, K.R., Pullen, D.J., Sather, H.N., Shuster, J.J., Devidas, M., Borowitz, M.J., et al. (2007) Risk- and Response-Based Classification of Childhood B-Precursor Acute Lymphoblastic Leukemia: A Combined Analysis of Prognostic Markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood, 109, 926-935. https://doi.org/10.1182/blood-2006-01-024729
Kaparou, M., Choumerianou, D., Perdikogianni, C., Martimianaki, G., Kalmanti, M. and Stiakaki, E. (2013) Enhanced Levels of the Apoptotic BAX/BCL-2 Ratio in Children with Acute Lymphoblastic Leukemia and High-Risk Features. Genetics and Molecular Biology, 36, 7-11. https://doi.org/10.1590/S1415-47572013005000003
Butt, H., Khalid, A. and Yaqoob, M. (2017) Polymorphisms of BCL2 Gene in Acute Lymphoblastic Leukemia Patients in Pakistan and Screening of Phytochemicals to Overcome Its Expression. Biology and Medicine (Aligarh), 10, Article ID: 1000424.
https://doi.org/10.4172/0974-8369.1000424
Moazami-Goudarzi, M., Farshdousti-Hagh, M., Hoseinpour-Feizi, A., Talebi, M., Movassaghpour-Akbari, A.A., Shams-Asanjan, K., et al. (2016) The Acute Lymphoblastic Leukemia Prognostic Scoring Whether It Is Possible by BCL-2, BAX Gene Promoter Genotyping. Caspian Journal of Internal Medicine, 7, 105-113.
